Preprint / Version 1

THE HEMOPHAGOCYTIC LYMPHYSTIOCYTOSIS SECONDARY TO SYSTEMIC LUPUS WITH REFRACTORY MIS-C CLINIC IN CHILDREN: A CASE REPORT

##article.authors##

DOI:

https://doi.org/10.1590/SciELOPreprints.1627

Keywords:

Hemophagocytic lymphohistiocytosis, Systemic Lupus Erythematosus, MISC, PIMS, Pandemic

Abstract

We report the case of an 11-year-old male adolescent, with symptoms of MISC-PIMS, negative RT-PCR and negative serology for COVID-19, family contact RT-PCR positive for COVID-19, treated in a referral hospital center, receiving treatment standardized for MIS-C, without response to initial therapy, despite receiving the same scheme on 3 occasions, classified as refractory, for which an expanded study was decided for other entities; finding hemophagocytic lymphohistiocytosis associated with systemic lupus erythematosus, an entity that often share similar inflammatory markers with the MISC, even usually confused with rheumatological, hematological and neoplastic entities, therefore the importance of reporting the case to identify this group refractory to treatment and identify another disease with expanded study, since it could be harmful or even fatal if a definitive diagnosis is not obtained.

Downloads

Download data is not yet available.

Author Biography

Kenny Chonlon Murillo, HOSPITAL EDGARDO REBAGLIATI MARTINS

  1. CDC U. Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C). https://www.cdc.gov/mis-c/hcp/
  2. Benseler SM, Silverman ED. Systemic lupus erythematosus. Pediatr Clin North Am, 52 (2005), pp. 443-67. http://dx.doi.org/10.1016/j.pcl.2005.01.010
  3. Lo JT, Tsai MJ, Wang LH, Huang MT, Yang YH, Lin YT, et al. Sex differences in pediatric systemic lupus erythematosus: A retrospective analysis of 135 cases. J Microbiol Immunol Infect, 32 (1999), pp. 173-8
  4. Font J, Cervera R, Espinosa G, Pallarés L, Ramos-Casals MJ iménez S, et al. Systemic lupus erythematosus in childhood: Analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis. 1998;57:456-9.
  5. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 Mar 3. doi: 10.1007/s00134-020-05991-x
  6. Whittaker, A. Bamford, J. Kenny, M. Kaforou, C.E. Jones, P. Shah, PIMS-TS Study Group and EUCLIDS and PERFORM Consortia, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA, 324 (2020), pp. 259-269. http://dx.doi.org/10.1001/jama.2020.10369
  7. J. Toubiana, C. Poirault, A. Corsia, F. Bajolle, J. Fourgeaud, F. Angoulvant, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: Prospective observational study. BMJ., 369 (2020), pp. m2094. http://dx.doi.org/10.1136/bmj.m2094

Posted

06/19/2026 — Updated on 12/30/2020

How to Cite

THE HEMOPHAGOCYTIC LYMPHYSTIOCYTOSIS SECONDARY TO SYSTEMIC LUPUS WITH REFRACTORY MIS-C CLINIC IN CHILDREN: A CASE REPORT. (2020). In SciELO Preprints. https://doi.org/10.1590/SciELOPreprints.1627

Section

Health Sciences

Plaudit